Barbara Ann Karmanos Cancer Institute
03/29/2025 | Press release | Archived content
IN THE NEWS – Multiple Myeloma Awareness Month: MGUS Recognition, Symptom Evaluation Drive Diagnosis
March 29, 2025
OncLive
Jeffrey Zonder, M.D., hematologist, leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team (MDT) and member of the Hematology Oncology MDT at Karmanos, explained that multiple myeloma could be diagnosed earlier by identifying monoclonal gammopathy of undetermined significance (MGUS) in routine bloodwork. Once identified, this allows for observation, as many multiple myeloma cases stem from MGUS.
Read the article here.
Barbara Ann Karmanos Cancer Institute published this content on March 29, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 11, 2025 at 12:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]